Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Smith & Nephew Snats ( (SNN) ) has provided an update.
On March 26, 2025, Sybella Stanley, a Non-Executive Director at Smith & Nephew, purchased 3,810 ordinary shares at £11.01 each on the London Stock Exchange. This transaction, disclosed under the UK Market Abuse Regulation, highlights the company’s commitment to transparency and may reflect confidence in the company’s future performance.
More about Smith & Nephew Snats
Smith & Nephew is a global medical technology company specializing in advanced wound management, orthopedics, and sports medicine. The company focuses on providing innovative solutions to improve patient care and outcomes.
YTD Price Performance: 16.43%
Average Trading Volume: 784,846
Technical Sentiment Signal: Sell
Current Market Cap: $12.4B
For detailed information about SNN stock, go to TipRanks’ Stock Analysis page.